Guided Therapeutics (GTHP) Share-based Compensation (2011 - 2026)
Guided Therapeutics (GTHP) posted Share-based Compensation of $25000.0 for Q4 2025, up 65.37% sequentially from $15118.0 in Q3 2025, and up 292.31% YoY from $6372.5 in Q4 2024.
Guided Therapeutics (GTHP) Share-based Compensation (2011 - 2026) Analysis & Trends
Guided Therapeutics has reported Share-based Compensation for 15 years, with the latest figure at $25000.0 in Q4 2025.
- Quarterly Share-based Compensation rose 292.31% year-over-year to $25000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27137.0 (up 38.62% YoY) and the FY2025 annual result came in at $377000.0, up 214.17% from the prior year.
- Share-based Compensation improved to $25000.0 in Q4 2025 per GTHP's latest filing, from $15118.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $1.1 million in Q2 2023 and troughed at -$54000.0 in Q4 2023.
- A 5-year average of $130116.6 and a median of $44000.0 in 2022 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 2443.18% in 2023, down 114.06% in 2023.
- Over 5 years, Share-based Compensation stood at $71000.0 in 2021, then surged by 440.85% to $384000.0 in 2022, then sank by 114.06% to -$54000.0 in 2023, then surged by 75.93% to -$13000.0 in 2024, then jumped by 292.31% to $25000.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $25000.0, $15118.0, and $131435.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 192,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 192,000.00 |
| Jun 30, 2026 | 192,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 15,118.00 |
| Sep 30, 2025 | 15,118.00 |
| Jun 30, 2025 | 131,435.00 |
| Jun 30, 2025 | 131,435.00 |
| Mar 31, 2025 | 19.00 |
| Mar 31, 2025 | 19.00 |
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 16,145.00 |
| Sep 30, 2024 | 16,145.00 |
| Jun 30, 2024 | 16,401.00 |
| Jun 30, 2024 | 16,401.00 |
| Mar 31, 2024 | 30.00 |
| Mar 31, 2024 | 30.00 |
| Dec 31, 2023 | -54,000.00 |
| Dec 31, 2023 | -54,000.00 |